Spotlight Pathology secures £1.5m of new investment to rollout Ai diagnostic tool

Spotlight Pathology

Spotlight Pathology, a Sci-Tech Daresbury based University of Manchester spin‑out developing AI‑powered tools for blood cancer diagnostics, has secured a new investment of £1.4 million to accelerate the commercial rollout of its flagship lymphoma diagnostic AI device.

The funding round was co-led by Liverpool City Region Seed Fund and UKI2S with continued support from existing investors including Deepbridge, Lyva Labs, EHE Ventures and River Capital. This latest raise ... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...

Close